US Stock MarketDetailed Quotes

TTNP Titan Pharmaceuticals

Watchlist
  • 5.5400
  • +0.0100+0.18%
Close Sep 13 16:00 ET
  • 5.5400
  • 0.00000.00%
Post 17:39 ET
5.06MMarket Cap-834P/E (TTM)

Titan Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-85.97%-2.07M
67.72%-613K
13.33%-7.09M
-42.24%-2.25M
2.03%-1.84M
37.07%-1.11M
35.93%-1.9M
-3.60%-8.18M
-46.07%-1.58M
17.20%-1.87M
Net income from continuing operations
-31.97%-2.09M
36.72%-1.06M
45.43%-5.57M
23.23%-1.97M
87.19%-338K
35.58%-1.59M
34.06%-1.68M
-16.29%-10.21M
-1.02%-2.57M
-37.75%-2.64M
Operating gains losses
----
----
---1.76M
---23K
----
----
----
----
----
----
Depreciation and amortization
-92.31%3K
-95.35%2K
-42.86%112K
-93.33%3K
-43.75%27K
-23.53%39K
-17.31%43K
-11.31%196K
-15.09%45K
-14.29%48K
Other non cash items
---1K
---1K
-94.91%23K
-94.67%24K
----
----
----
1,358.06%452K
1,116.22%450K
--0
Change In working capital
-86.55%23K
180.07%446K
-342.33%-916K
-156.26%-328K
-214.77%-202K
-57.14%171K
28.59%-557K
272.60%378K
-52.33%583K
116.46%176K
-Change in receivables
--95K
4,972.22%913K
-113.16%-10K
-176.92%-10K
-134.62%-18K
--0
116.98%18K
-90.16%76K
-95.85%13K
116.15%52K
-Change in inventory
----
----
--0
--0
----
----
----
434.29%187K
315.85%354K
--9K
-Change in prepaid assets
-44.00%98K
-20.20%-119K
7.93%177K
-72.22%55K
43.75%46K
-18.60%175K
64.77%-99K
0.61%164K
-40.54%198K
120.65%32K
-Change in payables and accrued expense
-317.95%-170K
11.11%-336K
-1,898.00%-899K
-549.40%-373K
-1,638.46%-226K
-73.01%78K
-22.33%-378K
103.37%50K
-81.39%83K
97.80%-13K
-Change in other working capital
--0
87.76%-12K
-85.86%-184K
--0
-104.17%-4K
-78.26%-82K
-16.67%-98K
-133.56%-99K
---65K
--96K
Cash from discontinued investing activities
Operating cash flow
-85.97%-2.07M
67.72%-613K
13.33%-7.09M
-42.24%-2.25M
2.03%-1.84M
37.07%-1.11M
35.93%-1.9M
-3.60%-8.18M
-46.07%-1.58M
17.20%-1.87M
Investing cash flow
Cash flow from continuing investing activities
732K
504K
0
0
Net PPE purchase and sale
----
----
---2K
----
----
----
----
--0
----
----
Net other investing changes
----
----
--734K
--506K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--732K
--504K
----
----
----
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
100.64%10M
406K
-43.63%4.98M
0
0
Net issuance payments of debt
----
----
--500K
--0
----
----
----
--0
--0
----
Net common stock issuance
----
----
--0
--0
----
----
----
-43.67%4.98M
--0
--0
Net preferred stock issuance
----
----
--9.5M
--406K
----
----
----
--0
--0
----
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
--4K
--0
--0
Cash from discontinued financing activities
Financing cash flow
----
----
100.64%10M
--406K
----
----
----
-43.63%4.98M
--0
--0
Net cash flow
Beginning cash position
399.11%6.16M
116.15%6.77M
-50.52%3.13M
72.09%8.11M
-98.15%122K
-85.22%1.23M
-50.52%3.13M
16.98%6.33M
-36.48%4.71M
-31.97%6.59M
Current changes in cash
-85.97%-2.07M
67.72%-613K
213.79%3.64M
15.39%-1.34M
526.43%7.99M
36.96%-1.11M
-194.15%-1.9M
-448.10%-3.2M
-45.40%-1.58M
17.20%-1.87M
End cash Position
3,254.10%4.09M
399.11%6.16M
116.18%6.77M
116.18%6.77M
72.09%8.11M
-98.15%122K
-85.22%1.23M
-50.52%3.13M
-50.52%3.13M
-36.48%4.71M
Free cash flow
-85.97%-2.07M
67.72%-613K
13.31%-7.09M
-42.37%-2.25M
2.03%-1.84M
37.07%-1.11M
35.93%-1.9M
-3.29%-8.18M
-45.40%-1.58M
17.20%-1.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -85.97%-2.07M67.72%-613K13.33%-7.09M-42.24%-2.25M2.03%-1.84M37.07%-1.11M35.93%-1.9M-3.60%-8.18M-46.07%-1.58M17.20%-1.87M
Net income from continuing operations -31.97%-2.09M36.72%-1.06M45.43%-5.57M23.23%-1.97M87.19%-338K35.58%-1.59M34.06%-1.68M-16.29%-10.21M-1.02%-2.57M-37.75%-2.64M
Operating gains losses -----------1.76M---23K------------------------
Depreciation and amortization -92.31%3K-95.35%2K-42.86%112K-93.33%3K-43.75%27K-23.53%39K-17.31%43K-11.31%196K-15.09%45K-14.29%48K
Other non cash items ---1K---1K-94.91%23K-94.67%24K------------1,358.06%452K1,116.22%450K--0
Change In working capital -86.55%23K180.07%446K-342.33%-916K-156.26%-328K-214.77%-202K-57.14%171K28.59%-557K272.60%378K-52.33%583K116.46%176K
-Change in receivables --95K4,972.22%913K-113.16%-10K-176.92%-10K-134.62%-18K--0116.98%18K-90.16%76K-95.85%13K116.15%52K
-Change in inventory ----------0--0------------434.29%187K315.85%354K--9K
-Change in prepaid assets -44.00%98K-20.20%-119K7.93%177K-72.22%55K43.75%46K-18.60%175K64.77%-99K0.61%164K-40.54%198K120.65%32K
-Change in payables and accrued expense -317.95%-170K11.11%-336K-1,898.00%-899K-549.40%-373K-1,638.46%-226K-73.01%78K-22.33%-378K103.37%50K-81.39%83K97.80%-13K
-Change in other working capital --087.76%-12K-85.86%-184K--0-104.17%-4K-78.26%-82K-16.67%-98K-133.56%-99K---65K--96K
Cash from discontinued investing activities
Operating cash flow -85.97%-2.07M67.72%-613K13.33%-7.09M-42.24%-2.25M2.03%-1.84M37.07%-1.11M35.93%-1.9M-3.60%-8.18M-46.07%-1.58M17.20%-1.87M
Investing cash flow
Cash flow from continuing investing activities 732K504K00
Net PPE purchase and sale -----------2K------------------0--------
Net other investing changes ----------734K--506K------------------------
Cash from discontinued investing activities
Investing cash flow ----------732K--504K--------------0--0----
Financing cash flow
Cash flow from continuing financing activities 100.64%10M406K-43.63%4.98M00
Net issuance payments of debt ----------500K--0--------------0--0----
Net common stock issuance ----------0--0-------------43.67%4.98M--0--0
Net preferred stock issuance ----------9.5M--406K--------------0--0----
Proceeds from stock option exercised by employees ----------0--0--------------4K--0--0
Cash from discontinued financing activities
Financing cash flow --------100.64%10M--406K-------------43.63%4.98M--0--0
Net cash flow
Beginning cash position 399.11%6.16M116.15%6.77M-50.52%3.13M72.09%8.11M-98.15%122K-85.22%1.23M-50.52%3.13M16.98%6.33M-36.48%4.71M-31.97%6.59M
Current changes in cash -85.97%-2.07M67.72%-613K213.79%3.64M15.39%-1.34M526.43%7.99M36.96%-1.11M-194.15%-1.9M-448.10%-3.2M-45.40%-1.58M17.20%-1.87M
End cash Position 3,254.10%4.09M399.11%6.16M116.18%6.77M116.18%6.77M72.09%8.11M-98.15%122K-85.22%1.23M-50.52%3.13M-50.52%3.13M-36.48%4.71M
Free cash flow -85.97%-2.07M67.72%-613K13.31%-7.09M-42.37%-2.25M2.03%-1.84M37.07%-1.11M35.93%-1.9M-3.29%-8.18M-45.40%-1.58M17.20%-1.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data